SL
ONC

Salomon & Ludwin’s BeOne Medicines Ltd ONC Stock Holding History

Salomon & Ludwin’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$581 Hold
2
– – ﹤0.01% 2050
2026
Q1 		$622 Hold
2
– – ﹤0.01% 2032
2025
Q4 		$641 Hold
2
– – ﹤0.01% 2080
2025
Q3 		$688 Hold
2
– – ﹤0.01% 2073
2025
Q2 		$489 Hold
2
– – ﹤0.01% 839
2025
Q1 		$544 Hold
2
– – ﹤0.01% 672
2024
Q4 		$369 Hold
2
– – ﹤0.01% 690
2024
Q3 		$449 Hold
2
– – ﹤0.01% 693
2024
Q2 		$285 Hold
2
– – ﹤0.01% 708
2024
Q1 		$313 Buy
+2
New +$322 ﹤0.01% 820

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Salomon & Ludwin's ONC Position: Q2 2026 in Review

Salomon & Ludwin held its BeOne Medicines Ltd (ONC) position steady in Q2 2026 at 2 shares worth $581. The position accounts for ﹤0.01% of the portfolio, ranked #2050.

Salomon & Ludwin first reported a position in ONC in Q1 2024 and has held it in 10 quarters since. The position peaked at $688 in Q3 2025. 283 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Salomon & Ludwin held 2 shares of BeOne Medicines Ltd worth $581 as of Q2 2026.
  • Salomon & Ludwin left its BeOne Medicines Ltd share count unchanged in Q2 2026.
  • BeOne Medicines Ltd made up ﹤0.01% of Salomon & Ludwin's portfolio in Q2 2026, its #2050 holding.
  • Salomon & Ludwin first reported a position in BeOne Medicines Ltd in Q1 2024 and has held it in 10 quarters since.
  • Salomon & Ludwin's BeOne Medicines Ltd position peaked at $688 in Q3 2025.
  • 283 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Salomon & Ludwin's 13F filing for Q2 2026, filed 7 Aug 2026.